Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
作者:
主题词
11-β-羟甾脱氢酶1型(11-beta-Hydroxysteroid Dehydrogenase Type 1);动物(Animals);细胞, 培养的(Cells, Cultured);疾病模型, 动物(Disease Models, Animal);药物评价, 临床前(Drug Evaluation, Preclinical);酶抑制剂(Enzyme Inhibitors);女(雌)性(Female);人类(Humans);不育, 女(雌)性(Infertility, Female);胰岛素抗药性(Insulin Resistance);卵巢(Ovary);哌嗪类(Piperazines);多囊卵巢综合征(Polycystic Ovary Syndrome);大鼠(Rats);大鼠, Sprague-Dawley(Rats, Sprague-Dawley);磺胺类(Sulfonamides);噻唑类(Thiazoles)
DOI
10.1016/j.metabol.2021.154749
PMID
33722534
发布时间
2021-06-24
- 浏览8
Metabolism
154749页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文